Novo Nordisk CEO says drugmaker actively pursuing large-scale M&A

Statements (4)

1. ● Neutral

   Novo Nordisk CEO opens the door to a major move for U.S. investors

   thestreet.comSep 23, 2026 18:33 UTC
2. ● Neutral

   Novo Nordisk CEO Mike Doustdar stated the pharmaceutical giant is actively considering mergers and acquisitions to strengthen its position in the competitive pharmaceutical market.

   breakingthenews.netSep 22, 2026 10:00 UTC
3. ▲ Bullish

   Novo Nordisk is partnering with Claude to speed drug research.

   inc.comSep 16, 2026 22:24 UTC
4. ● Neutral

   Novo Nordisk CEO Maziar Mike Doustdar says the company is not in a position to pursue large-scale M&A

   finance.yahoo.comAug 5, 2026 16:22 UTC